Intrinsic Therapeutics raises $18M

Woburn, MA-based Intrinsic Therapeutics has rounded up $18 million out of a $20 million offering. Though the filing didn't name investors, previous investors New Enterprise Associates, Spray Venture Partners, and New Leaf Venture Partners are listed as company directors in the SEC filing. The device maker markets a prosthetic to treat disc herniation. Article | Report

Suggested Articles

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.

Since launching Grail into the world in 2016, Illumina has watched the cancer blood test developer grow into a multibillion-dollar startup enterprise.